HIT Consultant

NOVEMBER 18, 2021

Benchling’s growth is fueled by the rapid rise of biotechnology , one of the world’s fastest-growing industries. As biotechnology companies come under increased pressure to deliver breakthroughs, they are turning to modern software to digitize all their scientific processes and centralize their data. Recent Traction/Milestones.

Biotechnology 97

Biotechnology Life Sciences Pharmaceuticals Accountability 97

HIT Consultant

AUGUST 5, 2022

Supply costs are often less significant in the cost structure of PPM companies, and campaigns run by large drug companies in an effort to increase market share for pharmaceuticals coming off patent expiration may generate additional opportunities for PPM companies to achieve higher margins on J-Code drug billing.

Life Sciences 98

Life Sciences Telemedicine Healthcare Biotechnology 98

Healthcare ECONOMIST

AUGUST 1, 2022

For large publicly traded pharmaceutical firms, research and other costs are public on their financial statements. It may appear on financial statements that successful pharmaceutical make outsized profits, but these figures must also take into account that many pharmaceutical firms have drugs that fail and the companies go out of business.

Pharmaceuticals 64

Pharmaceuticals Biotechnology Accountability 64

Bill Of Health

AUGUST 26, 2022

Myriad Genetics could boost investment in biotechnology R&D. Although genetic and other biotechnological research often begins in universities under federal funding, patents were clearly the focus of the university scientists racing to identify BRCA1 and BRCA2, as well as a gene relevant to Alzheimer’s.

Biotechnology 52

Biotechnology Pharmaceuticals 52

Bill Of Health

APRIL 24, 2023

An integral part of product life cycle management strategies for pharmaceutical corporations, product hops are reformulated versions of an often-lucrative brand-name drug, aimed at preserving market share after generics enter the marketplace. Glenn Cohen’s Health Law Policy, Bioethics, and Biotechnology Workshop at HLS.

Pharmaceuticals 125

Pharmaceuticals Biotechnology Integration 125

Bill Of Health

DECEMBER 8, 2023

It did not introduce unprecedented enablement principles, and, in practice, biotechnology genus claims, including antibody claims, were already limited. First, looking at chemical and biological patents in general, it is hard to argue that Amgen requires anything more stringent than non-antibody pharmaceutical cases from the 2010s.

Biotechnology 52

Biotechnology Life Sciences Pharmaceuticals Regulations 52

HIT Consultant

JANUARY 14, 2022

Verana Health is the exclusive data partner of the American Academy of Ophthalmology, American Urological Association, and American Academy of Neurology and collaborates with multinational pharmaceutical companies as well as emerging biotechnology and biopharmaceutical companies. Expansion Plans.

Life Sciences 98

Life Sciences Biotechnology Pharmaceuticals Population Health 98

HIT Consultant

OCTOBER 20, 2023

Fornari, co-founder of BioMech , brings more than 35 years of research, scientific and executive experience to this biotechnology group. Previously Dr. Fornari co-founded and was the CEO and medical director of Dominion Diagnostics, one of the country’s leading pharmaceutical monitoring laboratories and served there from 1997 to 2011.

Rehabilitation 105

Rehabilitation Pharmaceuticals Prevention Biotechnology 105

Bill Of Health

SEPTEMBER 22, 2022

These five students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from across Harvard. After graduating from law school, she has trained at Hogan Lovells in their Milan office, specializing in pharmaceutical patent litigation. Louis (USA). Katie Gu is a law student (JD 2024).

Biotechnology 52

Biotechnology Pharmaceuticals Medical Technology Regulations 52

Bill Of Health

OCTOBER 1, 2022

Since countries have sovereign rights over their biological resources , Indian companies enjoy easier access to and use of these biological resources for various commercial applications, including pharmaceuticals, cosmetics, and biotechnology.

Pharmaceuticals 52

Pharmaceuticals Biotechnology Regulations 52

Bill Of Health

SEPTEMBER 21, 2021

These six students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from across Harvard. Cathy’s research interests include telehealth access, pharmaceutical coverage, and payment reform. We are so excited to welcome a new group of Student Fellows to the Petrie-Flom Center family.

Biotechnology 57

Biotechnology Regulations Pharmaceuticals Doctors 57

HIT Consultant

NOVEMBER 3, 2022

Jonathan Montagu is President and Chief Executive Officer at HotSpot Therapeutics , a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for the treatment of cancer and autoimmune diseases. About Jonathan Montagu.

Biotechnology 98

Biotechnology Pharmaceuticals Healthcare Life Sciences 98

Bill Of Health

AUGUST 4, 2022

Not surprisingly, some representatives of the biotechnology industry, and many patent lawyers, reacted negatively to the decision, and have steadily lobbied Congress to restore patent protection for isolated and purified genomic sequences. Myriad Genetics (569 U.S. 576) the U.S.

Biotechnology 123

Biotechnology Life Sciences Pharmaceuticals Healthcare 123

Bill Of Health

MARCH 23, 2023

Is research in the interest of the public domain an activity exclusively developed by academic or healthcare entities, or can it be carried out by industry (pharmaceutical, biotechnology, technology companies, medical technology industries, and insurance providers)? If so, how?

Health Data 52

Health Data Regulations Biotechnology Pharmaceuticals 52

Bill Of Health

JULY 6, 2023

The Myriad case involved patents over isolated human DNA, leading courts to grapple with the “product of nature” issue in the fast-evolving biotechnology space. Further, the Court incorrectly assumed that most biotechnology products make use of patents on naturally occurring DNA. Myriad Genetics. Moderna’s patent no.

Biotechnology 16

Biotechnology Pharmaceuticals 16

HIT Consultant

DECEMBER 5, 2022

The National Center for Biotechnology Information (NCBI) reports that decentralized models recruited participants three times faster than the traditional model. Rachael delivered results working with pharmaceutical and biotech organizations to deliver operational fitness and market expansion strategies.

Biotechnology 52

Biotechnology Pharmaceuticals Integration Life Sciences 52

Bill Of Health

JANUARY 24, 2024

Indeed, the application of AI to the medical, pharmaceutical, and technology spaces is at least in large part, if not entirely, reliant on the use of copyrighted or otherwise protected materials to power tools that perform myriad functions from bench to bedside.

Pharmaceuticals 51

Pharmaceuticals Biotechnology Regulations Healthcare 51

Bill Of Health

JANUARY 12, 2023

Since biotechnology inventions can be covered by several patents, each of which may not be easy to identify through public searches, the decision to publish a consolidated list of patents is a move in the right direction. Interestingly, as of January 12, 2023, Moderna has listed 10 patents covering Spikevax (its mRNA vaccine) on its website.

Biotechnology 126

Biotechnology Prevention Pharmaceuticals 126

Bill Of Health

JANUARY 29, 2024

Dr. Devenot is also an affiliated researcher with Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Neşe Devenot, PhD is a Senior Lecturer in the University Writing Program at the Johns Hopkins University.

Biotechnology 142

Biotechnology Regulations Prevention Doctors 142

HIT Consultant

DECEMBER 6, 2022

is a life sciences consultant, educator and entrepreneur with extensive experience in pharmaceutical, basic scientific research, clinical medicine, toxicology, chemistry, and drug development. Frank Fornari, Ph.D.,

Doctors 52

Doctors Life Sciences Biotechnology Rehabilitation 52

Health Advances

SEPTEMBER 15, 2020

Investors in Hong Kong who are closer to China can better understand the equity story of Chinese biotechnology companies. Shanghai is also the home to an outsized number of healthcare companies with strengths in manufacturing, distribution, generic pharmaceutical products, and traditional Chinese medicines. explains Chen.

Pharmaceuticals 98

Pharmaceuticals Biotechnology Life Sciences Healthcare 98

Bill Of Health

OCTOBER 31, 2022

This problem is not new in the biotechnology sector. In the mRNA context, there are several entities claiming patent rights over various aspects of the technology – from RNA modification to delivery.

Biotechnology 67

Biotechnology Pharmaceuticals 67

Bill Of Health

APRIL 6, 2022

But still, multinational pharmaceutical manufacturers have protested even these modest changes from the status quo, arguing that there is no IP problem that needs to be fixed. Choosing an Indian company is savvy, since India thus far has resisted granting pharmaceutical manufacturers data exclusivity , which restricts speedy access to drugs.

Pharmaceuticals 123

Pharmaceuticals Prevention Regulations Biotechnology 123

Bill Of Health

MARCH 20, 2023

A selection of recent financings from February 2020 to April 2021 reveals a number of players, including Schrödinger, Insitro, AbCellera, Relay Therapeutics, Atomwise, Recursion Pharmaceuticals, XtalPi, and ExScientia, who have all raised hundreds of millions of dollars to pursue their AI-driven drug discovery pipelines.

Pharmaceuticals 125

Pharmaceuticals Biotechnology 125

Bill Of Health

NOVEMBER 12, 2021

were sourced from academia, and not large pharmaceutical companies. A recent study looking at intellectual property licensing out of MIT showed that by 2018, more than half of the top 30 drugs in the U.S. This highlights that academic institutions are the predominant source of medical innovation.

Pharmaceuticals 137

Pharmaceuticals Biotechnology 137

Bill Of Health

MARCH 1, 2024

Dr. Devenot is also an affiliated researcher with Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Neşe Devenot, PhD is a Senior Lecturer in the University Writing Program at the Johns Hopkins University.

Accountability 108

Accountability Biotechnology Rehabilitation Regulations 108

Bill Of Health

OCTOBER 24, 2023

Alicia Ely Yamin is a Lecturer on Law and the Senior Fellow on Global Health and Rights at the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics at Harvard Law School; and a Senior Advisor on Human Rights and Health Policy at Partners In Health.

Biotechnology 88

Biotechnology Regulations Prevention Accountability 88

Bill Of Health

JUNE 12, 2023

Finally, at the advanced pharmaceutical manufacturing stage , AI/ML is being used to optimize process design (e.g., At the postmarketing safety surveillance stage , AI/ML is helping automate the processing of individual case safety reports (ICSRs), the evaluation of cases (e.g.,

Pharmaceuticals 104

Pharmaceuticals Accountability Biotechnology Regulations 104

Bill Of Health

JANUARY 17, 2023

Two pharmaceutical giants of the pandemic, Moderna and BioNTech, are taking steps for increasing the manufacturing capacity for the COVID-19 vaccine in Africa. By Sarah Gabriele. Last March, Moderna announced its plan to set up a manufacturing facility in Kenya to produce messenger RNA (mRNA) vaccines, including COVID-19 shots.

Pharmaceuticals 89

Pharmaceuticals Biotechnology 89

Bill Of Health

JANUARY 18, 2024

Soekoe and Davis, both South African lawyers involved in litigation relating to transparency in vaccine contracts between the Government and pharmaceutical companies , detail the successful vindication of the right to access to information, entrenched in the South African Constitution and legislation.

Regulations 108

Regulations Prevention Accountability Pharmaceuticals 108

Bill Of Health

SEPTEMBER 20, 2023

Vaccines are pharmaceutical products, a critical tool in public and global health. I explore this analogy in a recently published article in the Journal of Law, Medicine and Ethics ( JLME ), Increasing Equity in the Transnational Allocation of Vaccines Against Emerging Pathogens: A Multi-Modal Approach.

Pharmaceuticals 123

Pharmaceuticals Accountability Prevention Biotechnology 123

Bill Of Health

MARCH 24, 2022

At the research and development (R&D) stage, government funders can bind producers to equity goals through targeted contractual provisions, as we explain in a recently-published Nature Biotechnology article. We summarize our proposals in the following sections. Pandemic Technology and the Contract Landscape.

Biotechnology 52

Biotechnology Prevention Pharmaceuticals 52

Bill Of Health

DECEMBER 20, 2023

Sanofi will affect innovation and the pharmaceutical industry. This post reviews the emerging post- Amgen literature, distilling the ruling’s likely impact on innovation and the pharmaceutical industry. Part III: How Will Amgen Affect the Pharmaceutical Industry? How Amgen v. This post has three parts. The Alliance of U.S.

Pharmaceuticals 62

Pharmaceuticals Biotechnology Prevention Regulations 62

Healthcare ECONOMIST

DECEMBER 26, 2023

I just came across a nice overview article titled The financial ecosystem of pharmaceutical R&D. Biotechnology companies (biotech) or small/medium-sized biopharmaceutical companies (SMEs) are most active in drug discovery, preclinical development and early-stage clinical development.

Biotechnology 93

Biotechnology Life Sciences Pharmaceuticals 93

Bill Of Health

SEPTEMBER 28, 2023

pharmaceutical market. Senator Sanders’ proposal within PAHPA was ultimately struck from the next iteration of the legislation due to concerns from the pharmaceutical industry and others that such a measure would chill innovation. Moreover, the NASDAQ Biotechnology Index increased by 374% from 1995 to 2000.

Pharmaceuticals 82

Pharmaceuticals Biotechnology Integration Public Health services 82

HIT Consultant

JANUARY 28, 2022

Benchling , pioneer of the R&D Cloud powering the biotechnology industry appoints Paul Robson, a cloud veteran as President of Field Operations and Elena Donio, the former CEO of Axiom and President of Concur, to its board, as a director and compensation committee chair. . – Leah Ray , Chief Customer Officer.

Biotechnology 98

Biotechnology Life Sciences Private Practices Healthcare Analytics 98

Bill Of Health

NOVEMBER 17, 2023

The EO lists biotechnology on its list of examples of “pressing security risks,” and the Secretary of Commerce is charged with enforcing detailed reporting requirements for AI use (with guidance from the National Institute of Standards and Technology) in developing biological outputs that could create security risks.

Biotechnology 99

Biotechnology Regulations Patient Safety Health Data 99